US Patent 11773164 Anti-CEACAM6 antibodies and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

January 29, 2020

Date of Patent

October 3, 2023

Patent Applicant

Bayer

Patent Application Number

16776326

Patent Citations

‌

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

‌

US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture

‌

US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

‌

US Patent 8779108 Targeted binding agents against B7-H1

‌

US Patent 8900587 Antibodies to human programmed death receptor PD-1

‌

US Patent 8609089 Compositions of PD-1 antagonists and methods of use

Patent Inventor Names

Yingzi Ge

Dorian Schönfeld

Philip Beckhove

Julian Glück

Jessica Pinkert

Christoph Freiberg

Eva-Maria Gutierrez

Mark Trautwein

Sven Golfier

Jörg Willuda

•••

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11773164

Patent Primary Examiner

CPC Code

Find more entities like US Patent 11773164 Anti-CEACAM6 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API